Drug Shortage Report for TEVA-DILTIAZEM

Last updated on 2018-05-30 History
Report ID 42610
Drug Identification Number 00862924
Brand name TEVA-DILTIAZEM
Common or Proper name DILTIAZEM
Company Name TEVA CANADA LIMITED
Market Status DORMANT
Active Ingredient(s) DILTIAZEM HYDROCHLORIDE
Strength(s) 30MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-03-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-05-30
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-05-30 French Compare
v3 2018-05-30 English Compare
v2 2018-03-13 French Compare
v1 2018-03-13 English Compare